Loading resource…

ACACIA-HCM Investigators
Nonobstructive hypertrophic cardiomyopathy (HCM) is a prevalent condition associated with significant morbidity and lacks proven medical therapies. This study investigates whether treatment with aficamten can provide benefits to patients suffering from this condition. The trial involved random assignment of adults with symptomatic nonobstructive HCM to receive either aficamten or a placebo, with various clinical outcomes measured over a 36-week period.
No account needed